Range
1.77 - 1.97
Vol / Avg.
12.7M/11.1M
Div / Yield
-
52 Wk
0.19 - 4.47
Mkt Cap
245.8M
Payout Ratio
-
Open
1.94
P/E
-
EPS
-0.1
Shares
137.3M
Outstanding
137.3M
Total Float
-
Benzinga - 3 days ago
Benzinga - Jun 1, 2021, 8:33AM
Benzinga - May 19, 2021, 8:54AM
Benzinga - May 18, 2021, 8:40AM
Benzinga - May 17, 2021, 8:31AM
Benzinga - May 17, 2021, 8:22AM
Benzinga - May 14, 2021, 8:35AM
Benzinga - Apr 29, 2021, 9:38AM
Benzinga - Apr 29, 2021, 8:12AM
Benzinga - Apr 23, 2021, 1:01PM
Benzinga - Apr 15, 2021, 12:06PM
Benzinga - Apr 15, 2021, 8:38AM
Benzinga - Apr 14, 2021, 8:36AM
Benzinga - Apr 8, 2021, 8:40AM
Benzinga - Apr 6, 2021, 8:45AM
Benzinga - Apr 1, 2021, 7:46AM
Benzinga - Mar 31, 2021, 4:31PM
load more
Sector: Health Care.Industry: Pharmaceuticals
Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders.

Earnings

see more
Q1 2021Est.ActualSurprise
EPS-0.020-0.090 -0.0700
REV7.400M1.241M-6.159M
Q4 2020Est.ActualSurprise
EPS-0.100-0.290 -0.1900
REV2.580M2.576M-4.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
JAGXJaguar Health0.56%245.8M

Jaguar Health Frequently Asked Questions

Q

How do I buy Jaguar Health (JAGX) stock?

A

You can purchase shares of Jaguar Health (NASDAQ: JAGX) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Jaguar Health's (JAGX) competitors?

A

Other companies in Jaguar Health’s space includes: Iterum Therapeutics (NASDAQ:ITRM), Xeris Pharmaceuticals (NASDAQ:XERS), CymaBay Therapeutics (NASDAQ:CBAY), Tricida (NASDAQ:TCDA) and Cerecor (NASDAQ:CERC).

Q

What is the target price for Jaguar Health (JAGX) stock?

A

The latest price target for Jaguar Health (NASDAQ: JAGX) was reported by HC Wainwright & Co. on November 18, 2019. The analyst firm set a price target for 3.00 expecting JAGX to rise to within 12 months (a possible 67.60% upside). 0 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Jaguar Health (JAGX)?

A

The stock price for Jaguar Health (NASDAQ: JAGX) is $1.79 last updated Today at 8:00:03 PM.

Q

Does Jaguar Health (JAGX) pay a dividend?

A

There are no upcoming dividends for Jaguar Health.

Q

When is Jaguar Health (NASDAQ:JAGX) reporting earnings?

A
Jaguar Health’s Q2 earnings are confirmed for after-market on August 12, 2021.
Q

Is Jaguar Health (JAGX) going to split?

A

There is no upcoming split for Jaguar Health.

Q

What sector and industry does Jaguar Health (JAGX) operate in?

A

Jaguar Health is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.